Jeffrey Aronin is the entrepreneur responsible for founding Paragon Biosciences. The company develops innovative medicines to treat unmet medical diseases. This is accomplished by determining the cause of the disease, using top talent and breakthrough science. The company’s track record is strong with approvals for thirteen new drugs that focus on the needs of the patients. Jeffrey Aronin brought together leading talent to provide treatments for medical conditions. These new drugs are developed by clinical experts. Biotech startups are incubated and invested in by Paragon Biosciences. This drives drug development strategies forward.
Jeffrey Aronin has a passion for helping people who require suboptimal treatments or have no treatments available. He has provided support for small groups with no options. Rare diseases are usually overlooked by the large pharma and biotech companies when they affect under 200,000 people. These areas are ideal for the strategies of Paragon to efficiently have important medicines approved. Jeffrey Aronin realizes time is a critical factor in improving patient’s lives with the development of new medicines. Paragon Biosciences provides startup companies with the human and financial resources to commercialize and develop novel medications. Jeffrey Aronin supports the leaders of biotech trying to break through traditional barriers to find new ways to help patients.
Jeffrey Aronin provides healthcare professionals with more resources and options to bring patients important medicines. Paragon Biosciences addresses the needs unmet by the other companies. They move medicines with scientific rigor through the process of clinical development. The companies they help are focused on unmet needs including medicines for EB or epidermolysis bullosa. This skin disease is rare, devastating and the slightest abrasion will result in blisters. Paragon is assisting with disorders of the central nervous system focusing on cataplexy and narcolepsy. The H3 receptor has potential for helping people with these conditions.
Jeffrey Aronin has an excellent understanding of medicine and science. His background is extremely well suited for the biotech and healthcare industries. He is also a philanthropist. He gives back by raising awareness of rare diseases, advancing science, supporting community development and improving education. He provides mentorship and advice to both startup companies and experienced leaders.